TestoRapid (vial) from the manufacturer Alpha-Pharma (India) is an injectable steroid with high anabolic and androgenic activity. It is characterized by a quick action after application – up to 2-3 days. For sporting purposes it is recommended mainly for men: for high-quality muscle growth without excess fluid, fat and recoil, to increase strength and endurance.
TESTORAPID: DESCRIPTION AND FEEDBACK
TestoRapid has the active substance testosterone propionate – a short testosterone ester, which differs from its analogues (see phenylpropionate, cypionate and enanthate) not so much by effect, as by severity and duration of action. It is considered one of the most “light” products of testosterone, in connection with which it is recommended for sports use even for women (but only in the minimum dosage).
TestoRapid, when properly constructed and conducted, effectively promotes anabolic and interferes with catabolic processes — consequently, promotes growth and prevents muscle destruction. It appears to be a minimally (weakly) aromatizing steroid, therefore fluid retention does not become pronounced. In connection with the specifics of the effect, it is used both in mass set and drying courses (often combined with other drugs).
TESTORAPID: COURSE OF INJECTIONS
The average dosage of TestoRapid recommended for men is 100 mg with a frequency of administration every other day. For women – 50-100 mg every 5-7 days, so as not to provoke virilization. Effective doses are selected only individually, otherwise they may be excessive or insufficient, which is unacceptable in both cases: on the one hand, side effects, on the other – inefficiency.
The course of TestoRapida effectively lasts an average of 6-8 weeks. Upon its completion, as a rule, post-course therapy is carried out, which includes taking tamoxifen or clomiphene for several weeks (an average of 3 weeks) to consolidate the results and prevent consequences. For optimal results, it is preferable to conduct a combined course, rather than exceeding the recommended dosage and duration of use of the drug.